Use of NKG2D Inhibitors for Treating Cardiovascular and Metabolic Diseases, Such as Type 2 Diabetes

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20150376281A1
SERIAL NO

14850688

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention provides methods, compositions and kits for treating and detecting type 2 diabetes and/or conditions that may be regulated or normalised via inhibition of NKG2D, such as cardiovascular diseases.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
THE PENN STATE RESEARCH FOUNDATION304 OLD MAIN UNIVERSITY PARK PA 16802

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Bodvarsdottir, Thora Brynja Vedbaek, DK 3 10
Petersen, Jacob Sten Charlottenlund, DK 11 119
Raulet, David H Berkeley, US 5 14
Xia, Mingcan State College, US 5 6
Xiong, Na State College, US 5 6

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation